Results 221 to 230 of about 6,276,987 (290)

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

Optimising clinical trial design choices in inflammatory bowel disease. [PDF]

open access: yesBMJ Open Gastroenterol
Bossuyt P   +4 more
europepmc   +1 more source

Behavioral and electrophysiological evaluation of the anesthetic therapeutic window of thyme essential oil in tambaqui (Colossoma macropomum). [PDF]

open access: yesFish Physiol Biochem
da Luz Froz MJ   +7 more
europepmc   +1 more source

Medicine Requirements and Budget Implication for Pediatric Acute Lymphoblastic Leukemia in Indonesia: A Morbidity-Based Approach. [PDF]

open access: yesRisk Manag Healthc Policy
Argadiredja DNS   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy